Skip to main content

Table 1 Characteristics of included studies

From: The effect of midazolam on pain control after knee arthroscopy: a systematic review and meta-analysis

No.

Author

Midazolam group

Control group

Jadad scores

Number

Age (years)

Male (n)

Body mass (kg)

Surgery duration (min)

Methods

Number

Age (years)

Male (n)

Body mass (kg)

Surgery duration (min)

Methods

 

1

Sajedi 2014

25

26.9 ± 5.4

19

71.9 ± 4.5

49.2 ± 4.3

75 μg/kg intraarticular injection of midazolam and 10 ml intravenous injection of isotonic saline

25

27.5 ± 5.1

22

70.7 ± 4.5

49.2 ± 4.6

Intraarticular and intravenous injection of isotonic saline

5

2

Nanjegowda 2011

25

32.48 ± 11.13

9

63.36 ± 11.79

0.5% hyperbaric bupivacaine with preservative-free midazolam 2 mg intrathecally

25

35.24 ± 10.91

10

63.36 ± 11.79

0.5% hyperbaric bupivacaine with saline intrathecally

3

3

He 2010

15

23–34

46.7–62.5

75 μg/kg intraarticular injection of midazolam

15

23–34

46.7–62.5

Intraarticular injection of saline

3

4

Cagla 2009

20

18–57

9

50–110

Ketamine 0.15 mg/kg and midazolam 0.01 mg/kg intravenously

20

16–65

11

55–95

Intravenous ketamine 0.15 mg/kg

4

5

LI 2008

35

18–65

Intraarticular 2% lidocaine and 2 mg midazolam

35

18–65

Intraarticular 2% lidocaine

3

6

Batra 2008

20

41 ± 4

14

69 ± 4

Intraarticular midazolam 75 μg/kg

20

40 ± 4.6

13

75 ± 3

Intraarticular saline

4